Biocorp
Designs, develops, and manufactures medical devices and drug delivery systems.
ALCOR | PA
Overview
Corporate Details
- ISIN(s):
- FR0012788065
- LEI:
- 969500TKUAME6031UQ32
- Country:
- France
- Address:
- PARC INDUSTRIEL TECH LAVAUR LA BECHADE, 63500 ISSOIRE
- Website:
- https://biocorpsys.com
- Sector:
- Manufacturing
Description
Biocorp designs, develops, and manufactures medical devices and drug delivery systems for the pharmaceutical industry. The company specializes in combining precision engineering with connected technologies to improve patient treatment adherence and outcomes. Its portfolio includes both connected and non-connected devices, such as smart caps for inhalers (Inspair), pen injectors, and systems for drug reconstitution and safety. Biocorp manages the entire value chain, from research and development to manufacturing and final packaging, leveraging its expertise in plastics processing and advanced technological innovation. Since October 2023, Biocorp has been a subsidiary of Novo Nordisk.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-09-29 19:00 |
Rapport financier semestriel
|
French | 1.8 MB | ||
| 2016-09-29 19:00 |
Communiqués de mise à disposition de documents / Modalités de mise à dispositio…
|
French | 419.6 KB | ||
| 2016-09-27 09:30 |
Communicated under the obligation to provide permanent information / Activity o…
|
English | 575.4 KB | ||
| 2016-09-27 09:30 |
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
|
French | 469.5 KB | ||
| 2016-07-12 19:00 |
Rachat d'actions / Contrat de liquidité Information relative au contrat de liq…
|
French | 346.4 KB | ||
| 2016-05-09 19:00 |
Communiqués au titre de l'obligation d'information permanente / Autres communiq…
|
French | 427.0 KB | ||
| 2016-05-09 19:00 |
Communicated under the obligation to provide permanent information / Other comm…
|
English | 501.5 KB | ||
| 2016-04-07 09:00 |
Communicated under the obligation to provide permanent information / Activity o…
|
English | 407.4 KB | ||
| 2016-04-07 09:00 |
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
|
French | 357.2 KB | ||
| 2016-04-06 19:00 |
Rapport financier annuel
|
French | 2.0 MB | ||
| 2016-04-06 19:00 |
Communiqués au titre de l'obligation d'information permanente / Communiqué sur …
|
French | 366.8 KB | ||
| 2016-04-06 19:00 |
Communicated under the obligation to provide permanent information / Communicat…
|
English | 364.8 KB | ||
| 2016-03-24 18:00 |
Communiqués au titre de l'obligation d'information permanente / Autres communiq…
|
French | 223.8 KB | ||
| 2016-02-11 18:00 |
Communicated under the obligation to provide permanent information / Other comm…
|
English | 316.6 KB | ||
| 2016-02-11 18:00 |
Communiqués au titre de l'obligation d'information permanente / Autres communiq…
|
French | 319.9 KB |
Automate Your Workflow. Get a real-time feed of all Biocorp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biocorp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biocorp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-14 | N/A | Other | Other | 30,000 | 1,050,000.00 EUR |
| 2023-09-14 | N/A | Other | Other | 7,450 | 260,750.00 EUR |
| 2023-09-14 | N/A | Other | Other | 6,000 | 210,000.00 EUR |
| 2023-08-04 | N/A | Other | Sell | 1,998,800 | 69,958,000.00 EUR |
Peer Companies
